Bird & Bird selected to join the WeWork EMEA Legal Panel

Contacts

graeme payne module
Graeme Payne

Partner
UK

I'm the global head of our International Retail & Consumer sector group. As a partner in our international Commercial group in London, I work primarily with retail & consumer focussed businesses on their domestic and international growth and expansion strategies.

WeWork, the global space community and services company, invited 30 legal advisors and alternative legal service providers from around the world to apply to be a part of its Legal Panel. The aim was to appoint a panel of preferred legal partners to advise WeWork during the next chapter of the company’s growth.

The Bird & Bird team will advise WeWork on issues relating to commercial, corporate, data privacy and cyber security matters. The work will be led by the co-head of the international Retail & Consumer sector group at Bird & Bird Graeme Payne (Commercial, London) and assisted by partners Ian Edwards (Commercial, London), Gabriel Voisin (Privacy & Data Protection, London) and Shing Lo (Corporate, London).

Graeme Payne, co-head of the international Retail & Consumer sector group at Bird & Bird says: "We are delighted to be selected to join the WeWork EMEA Legal Panel. The company's strong focus around using technology innovatively is perfectly in line with Bird & Bird's strategy. We look forward to supporting the team at WeWork in the months ahead."


News & Deals

More News & Deals
Deal Bird & Bird advises Theon on the acquisition of Kappa Optronics

Aug 12 2025

Read More
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
Deal Bird & Bird advises ACTUM Digital on Strategic Acquisition of Kuehlhaus AG

Aug 05 2025

Read More
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More